These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1679672)
1. Safety issues relating to long-term treatment with histamine H2-receptor antagonists. Sabesin SM Aliment Pharmacol Ther; 1993; 7 Suppl 2():35-40. PubMed ID: 8103374 [TBL] [Abstract][Full Text] [Related]
2. The safety of drugs used in acid-related disorders and functional gastrointestinal disorders. Parikh N; Howden CW Gastroenterol Clin North Am; 2010 Sep; 39(3):529-42. PubMed ID: 20951916 [TBL] [Abstract][Full Text] [Related]
3. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy. Lima M; Holdcroft C Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655 [TBL] [Abstract][Full Text] [Related]
4. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection. Freston JW Am J Gastroenterol; 1987 Dec; 82(12):1242-9. PubMed ID: 2891294 [TBL] [Abstract][Full Text] [Related]
7. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis. Barradell LB; McTavish D Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883 [TBL] [Abstract][Full Text] [Related]
8. Long-term treatment for gastric and duodenal ulcer. Di Mario F; Battaglia G; Pasqualetti P; Vio A; Gottardello L; Grassi SA Ital J Gastroenterol; 1990; 22 Suppl 2():24-8. PubMed ID: 1983413 [TBL] [Abstract][Full Text] [Related]